Trends is free while in Beta
114%
(5y)
154%
(1y)
162%
(3mo)

About Protein S

Protein S is a vitamin K–dependent plasma glycoprotein that functions as a cofactor to protein C in the anticoagulation pathway, with clinical relevance to protein S deficiency and thrombotic risk assessment and management.

Trend Decomposition

Trend Decomposition

Trigger: Advances in coagulation biology and diagnostic testing highlighting Protein S’s role in thrombosis risk and inherited/acquired deficiencies.

Behavior change: Increased clinician emphasis on Protein S level and function testing in thrombosis workups and personalized anticoagulation strategies.

Enabler: Improved assays for Protein S activity and antigen levels, plus greater awareness of inherited coagulopathies.

Constraint removed: Availability of reliable Protein S diagnostics and integration into standard thrombophilia panels.

PESTLE Analysis

PESTLE Analysis

Political: Regulatory scrutiny of coagulation diagnostics influences test approvals and reimbursement.

Economic: Growing demand for targeted thrombosis management can drive test adoption and therapeutic market expansion.

Social: Increased patient awareness of hereditary clotting disorders and family screening considerations.

Technological: Advances in assay sensitivity, multiplex testing, and data analytics improve Protein S measurement.

Legal: Compliance with clinical laboratory standards and privacy laws in genetic and coagulation testing.

Environmental: Not applicable / minimal impact in this context.

Jobs to be done framework

Jobs to be done framework

What problem does this trend help solve?

Identifying and managing thrombotic risk due to Protein S deficiency or dysfunction.

What workaround existed before?

Broad thrombophilia panels without specific Protein S focus and less precise risk stratification.

What outcome matters most?

Certainty in risk assessment and effective, individualized anticoagulation decisions.

Consumer Trend canvas

Consumer Trend canvas

Basic Need: Safe, effective management of thrombotic risk.

Drivers of Change: Better understanding of Protein S biology and improved diagnostics.

Emerging Consumer Needs: Clear interpretation of Protein S test results and personalized treatment options.

New Consumer Expectations: Access to precise testing and integrated care pathways for coagulation disorders.

Inspirations / Signals: Research showing Protein S influence on venous thromboembolism risk.

Innovations Emerging: Novel Protein S assays, standardization efforts, and potential targeted therapies.